Autogenous Vaccine Market - Chronic Infection Treatment and Microbial-Specific Immunization
Market Overview
The autogenous vaccine market is experiencing infectious disease emphasis where patient-specific bacterial isolate vaccines, chronic infection management, and recurrent infection prevention through customized immunization. The autogenous vaccine market is projected to exceed USD 2.1 billion through 2030, with infection emphasis driven by antibiotic resistance limiting treatment...
